So, for a clear conceptualization, biochemical validation through co-immunoprecipitation (co-IP) or pull-down assays will be essential to confirm the physical interaction between FOXO proteins and the cGAS–STING complex and to characterize its regulatory relevance in NSCLC. Here, CGAS is linked to non-small cell lung carcinoma.